Equities analysts expect Marchex, Inc. (NASDAQ:MCHX – Get Rating) to report $13.81 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Marchex’s earnings. The highest sales estimate is $14.30 million and the lowest is $13.31 million. Marchex posted sales of $14.01 million in the same quarter last year, which suggests a negative year over year growth rate of 1.4%. The business is scheduled to issue its next quarterly earnings report on Monday, January 1st.
According to Zacks, analysts expect that Marchex will report full year sales of $55.47 million for the current fiscal year, with estimates ranging from $54.74 million to $56.20 million. For the next fiscal year, analysts expect that the business will report sales of $59.00 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that cover Marchex.
Marchex (NASDAQ:MCHX – Get Rating) last issued its earnings results on Thursday, May 12th. The technology company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.04. Marchex had a negative return on equity of 8.10% and a negative net margin of 1.19%. During the same quarter in the prior year, the business posted ($0.10) EPS.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Millennium Management LLC increased its position in Marchex by 41.4% in the third quarter. Millennium Management LLC now owns 33,816 shares of the technology company’s stock worth $101,000 after buying an additional 9,898 shares in the last quarter. State Street Corp raised its stake in Marchex by 7.8% during the 1st quarter. State Street Corp now owns 136,696 shares of the technology company’s stock worth $313,000 after acquiring an additional 9,881 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Marchex by 2.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 200,869 shares of the technology company’s stock valued at $498,000 after purchasing an additional 4,934 shares in the last quarter. First Eagle Investment Management LLC boosted its position in shares of Marchex by 256.5% in the fourth quarter. First Eagle Investment Management LLC now owns 205,801 shares of the technology company’s stock worth $510,000 after purchasing an additional 148,078 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Marchex by 2.6% in the fourth quarter. Geode Capital Management LLC now owns 269,674 shares of the technology company’s stock worth $668,000 after purchasing an additional 6,921 shares in the last quarter. Institutional investors own 72.41% of the company’s stock.
Marchex stock opened at $2.11 on Tuesday. Marchex has a one year low of $1.65 and a one year high of $3.63. The business’s fifty day moving average is $2.10 and its 200 day moving average is $2.36. The stock has a market capitalization of $89.19 million, a PE ratio of -105.50 and a beta of 1.93.
About Marchex (Get Rating)
Marchex, Inc operates as an analytics and solutions company that helps businesses connect, drive, measure, and convert callers into customers in the United States and Canada. Its products include Marchex Call Analytics, an analytics platform for enterprises, which depend on inbound phone calls to drive sales, appointments, and reservations; Marchex Call Analytics, Conversation Edition that enable actionable insights for enterprise, mid-sized, and small businesses; Text Analytics and Communications, a solution for intelligent mobile messaging, which enables sales, marketing, and operations teams in businesses to engage in two-way communications with field staff, prospects, and customers through text/SMS messages; Call Monitoring for call recording; and Marchex Marketing Edge, an analytics solution for marketers in enterprise, mid-sized and small businesses that depend on inbound phone calls to drive sales, appointments and reservations.
- Get a free copy of the StockNews.com research report on Marchex (MCHX)
- MarketBeat Podcast: Trading Volatile Markets While Preserving Capital
- Option Care Health Stock is Making a Healthy Pullback
- Warby Parker Stock Is A High-Probability Candidate For A Short-Squeeze
- Concentrix: High Debt and Struggling Margins
- Recession Fears Mount After Weak Manufacturing Data
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.